Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Innate immunosensing of DNA in cellular senescence.

Glück S, Ablasser A.

Curr Opin Immunol. 2018 Oct 5;56:31-36. doi: 10.1016/j.coi.2018.09.013. [Epub ahead of print] Review.

PMID:
30296662
2.

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC).

Nekljudova V, Loibl S, von Minckwitz G, Schneeweiss A, Glück S, Crane R, Li H, Luo X.

Contemp Clin Trials. 2018 Aug;71:194-198. doi: 10.1016/j.cct.2018.06.016. Epub 2018 Jun 26.

PMID:
29959104
3.

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial.

Yardley DA, Coleman R, Conte P, Cortes J, Brufsky A, Shtivelband M, Young R, Bengala C, Ali H, Eakel J, Schneeweiss A, de la Cruz-Merino L, Wilks S, O'Shaughnessy J, Glück S, Li H, Miller J, Barton D, Harbeck N; tnAcity investigators.

Ann Oncol. 2018 Aug 1;29(8):1763-1770. doi: 10.1093/annonc/mdy201.

4.

Exploring dynamism of cultural ecosystems services through a review of environmental education research.

Gould RK, Coleman K, Gluck SB.

Ambio. 2018 Apr 11. doi: 10.1007/s13280-018-1045-8. [Epub ahead of print] Review.

PMID:
29644621
5.
6.

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis.

Mahtani RL, Parisi M, Glück S, Ni Q, Park S, Pelletier C, Faria C, Braiteh F.

Cancer Manag Res. 2018 Feb 8;10:249-256. doi: 10.2147/CMAR.S150960. eCollection 2018.

7.

Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.

Rivera VR, Jean-Juste MA, Gluck SC, Reeder HT, Sainristil J, Julma P, Peck M, Joseph P, Ocheretina O, Perodin C, Secours R, Duran-Mendicuti M, Hashiguchi L, Cremieux PY, Koenig SP, Pape JW.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1140-1146. doi: 10.5588/ijtld.17.0049.

8.

Microchip capillary gel electrophoresis combined with lectin affinity enrichment employing magnetic beads for glycoprotein analysis.

Engel NY, Weiss VU, Wenz C, Glück S, Rüfer A, Kratzmeier M, Marchetti-Deschmann M, Allmaier G.

Anal Bioanal Chem. 2017 Nov;409(28):6625-6634. doi: 10.1007/s00216-017-0615-0. Epub 2017 Sep 20.

9.

Wide Disagreement Between Alternative Assessments of Premorbid Physical Activity: Subjective Patient and Surrogate Reports and Objective Smartphone Data.

Gluck S, Summers MJ, Goddard TP, Andrawos A, Smith NC, Lange K, Iwashyna TJ, Deane AM.

Crit Care Med. 2017 Oct;45(10):e1036-e1042. doi: 10.1097/CCM.0000000000002599.

PMID:
28915184
10.

A scoping review of use of wearable devices to evaluate outcomes in survivors of critical illness.

Gluck S, Chapple LS, Chapman MJ, Iwashyna TJ, Deane AM.

Crit Care Resusc. 2017 Sep;19(3):197-204. Review.

PMID:
28866969
11.

Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence.

Glück S, Guey B, Gulen MF, Wolter K, Kang TW, Schmacke NA, Bridgeman A, Rehwinkel J, Zender L, Ablasser A.

Nat Cell Biol. 2017 Sep;19(9):1061-1070. doi: 10.1038/ncb3586. Epub 2017 Jul 31.

12.

Rotavirus replication is correlated with S/G2 interphase arrest of the host cell cycle.

Glück S, Buttafuoco A, Meier AF, Arnoldi F, Vogt B, Schraner EM, Ackermann M, Eichwald C.

PLoS One. 2017 Jun 16;12(6):e0179607. doi: 10.1371/journal.pone.0179607. eCollection 2017.

13.

Community network for deaf scientists.

Adler HJ, Anbuhl KL, Atcherson SR, Barlow N, Brennan MA, Brigande JV, Buran BN, Fraenzer JT, Gale JE, Gallun FJ, Gluck SD, Goldsworthy RL, Heng J, Hight AE, Huyck JJ, Jacobson BD, Karasawa T, Kovačić D, Lim SR, Malone AK, Nolan LS, Pisano DV, Rao VRM, Raphael RM, Ratnanather JT, Reiss LAJ, Ruffin CV, Schwalje AT, Sinan M, Stahn P, Steyger PS, Tang SJ, Tejani VD, Wong V.

Science. 2017 Apr 28;356(6336):386-387. doi: 10.1126/science.aan2330. Epub 2017 Apr 27. No abstract available.

14.

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.

Chow LWC, Biganzoli L, Leo AD, Kuroi K, Han HS, Patel J, Huang CS, Lu YS, Zhu L, Chow CYC, Loo WTY, Glück S, Toi M.

Asia Pac J Clin Oncol. 2017 Dec;13(6):372-378. doi: 10.1111/ajco.12682. Epub 2017 Mar 28.

PMID:
28371190
15.

A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear.

Landegger LD, Pan B, Askew C, Wassmer SJ, Gluck SD, Galvin A, Taylor R, Forge A, Stankovic KM, Holt JR, Vandenberghe LH.

Nat Biotechnol. 2017 Mar;35(3):280-284. doi: 10.1038/nbt.3781. Epub 2017 Feb 6.

16.

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up.

Antoni MH, Jacobs JM, Bouchard LC, Lechner SC, Jutagir DR, Gudenkauf LM, Blomberg BB, Glück S, Carver CS.

Gen Hosp Psychiatry. 2017 Jan - Feb;44:16-21. doi: 10.1016/j.genhosppsych.2016.10.002. Epub 2016 Oct 22.

17.

MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts.

Gaur N, Karouzakis E, Glück S, Bagdonas E, Jüngel A, Michel BA, Gay RE, Gay S, Frank-Bertoncelj M, Neidhart M.

RMD Open. 2016 Oct 14;2(2):e000299. eCollection 2016.

18.

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer.

Glück S.

Clin Breast Cancer. 2017 Apr;17(2):79-90. doi: 10.1016/j.clbc.2016.08.004. Epub 2016 Aug 25. Review.

19.

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Koru-Sengul T, Santander AM, Miao F, Sanchez LG, Jorda M, Glück S, Ince TA, Nadji M, Chen Z, Penichet ML, Cleary MP, Torroella-Kouri M.

Breast Cancer Res Treat. 2016 Jul;158(1):113-126. doi: 10.1007/s10549-016-3847-3. Epub 2016 Jun 9.

20.

Finding patterns and learning words: Infant phonotactic knowledge is associated with vocabulary size.

Graf Estes K, Gluck SC, Grimm KJ.

J Exp Child Psychol. 2016 Jun;146:34-49. doi: 10.1016/j.jecp.2016.01.012. Epub 2016 Feb 22.

21.

Theory of mind and executive function in Chinese preschool children.

Duh S, Paik JH, Miller PH, Gluck SC, Li H, Himelfarb I.

Dev Psychol. 2016 Apr;52(4):582-91. doi: 10.1037/a0040068. Epub 2016 Feb 4. Erratum in: Dev Psychol. 2016 Apr;52(4):571.

PMID:
26845504
22.

Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.

Yardley DA, Brufsky A, Coleman RE, Conte PF, Cortes J, Glück S, Nabholtz JM, O'Shaughnessy J, Beck RM, Ko A, Renschler MF, Barton D, Harbeck N.

Trials. 2016 Feb 3;17:63. doi: 10.1186/s13063-016-1195-6. No abstract available.

23.

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.

Yardley DA, Brufsky A, Coleman RE, Conte PF, Cortes J, Glück S, Nabholtz JM, O'Shaughnessy J, Beck RM, Ko A, Renschler MF, Barton D, Harbeck N.

Trials. 2015 Dec 16;16:575. doi: 10.1186/s13063-015-1101-7. Erratum in: Trials. 2016;17:63.

24.

The incidence of ocular candidiasis and evaluation of routine opthalmic examination in critically ill patients with candidaemia.

Gluck S, Headdon WG, Tang D, Bastian IB, Goggin MJ, Deane AM.

Anaesth Intensive Care. 2015 Nov;43(6):693-7.

25.

Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer.

Bouchard LC, Antoni MH, Blomberg BB, Stagl JM, Gudenkauf LM, Jutagir DR, Diaz A, Lechner S, Glück S, Derhagopian RP, Carver CS.

Psychosom Med. 2016 Jan;78(1):26-37. doi: 10.1097/PSY.0000000000000261.

26.

A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up.

Stagl JM, Lechner SC, Carver CS, Bouchard LC, Gudenkauf LM, Jutagir DR, Diaz A, Yu Q, Blomberg BB, Ironson G, Glück S, Antoni MH.

Breast Cancer Res Treat. 2015 Nov;154(2):319-28. doi: 10.1007/s10549-015-3626-6. Epub 2015 Oct 30.

27.

Obligations and Concerns of an Organization Like the Center for Talented Youth.

Hansen ET, Gluck S, Shelton AL.

Hastings Cent Rep. 2015 Sep-Oct;45(5 Suppl):S66-72. doi: 10.1002/hast.502.

PMID:
26413952
28.

Use of tracheal tubes as intercostal catheters.

Gluck S, Ellis DY, Pearce AP.

Emerg Med Australas. 2015 Oct;27(5):497-8. doi: 10.1111/1742-6723.12449. Epub 2015 Jul 31. No abstract available.

PMID:
26235515
29.

Ethnic differences in types of social support from multiple sources after breast cancer surgery.

Jutagir DR, Gudenkauf LM, Stagl JM, Carver CS, Bouchard LC, Lechner SC, Glück S, Blomberg BB, Antoni MH.

Ethn Health. 2016 Oct;21(5):411-25. doi: 10.1080/13557858.2015.1066494. Epub 2015 Jul 28.

30.

Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2- Advanced Breast Cancer From a US Payer Perspective.

Xie J, Hao Y, Zhou ZY, Qi CZ, De G, Glück S.

Clin Breast Cancer. 2015 Oct;15(5):e263-76. doi: 10.1016/j.clbc.2015.04.001. Epub 2015 Apr 23.

PMID:
26048087
31.

Brief cognitive-behavioral and relaxation training interventions for breast cancer: A randomized controlled trial.

Gudenkauf LM, Antoni MH, Stagl JM, Lechner SC, Jutagir DR, Bouchard LC, Blomberg BB, Glück S, Derhagopian RP, Giron GL, Avisar E, Torres-Salichs MA, Carver CS.

J Consult Clin Psychol. 2015 Aug;83(4):677-688. doi: 10.1037/ccp0000020. Epub 2015 May 4.

32.

Challenges of glycoprotein analysis by microchip capillary gel electrophoresis.

Engel N, Weiss VU, Wenz C, Rüfer A, Kratzmeier M, Glück S, Marchetti-Deschmann M, Allmaier G.

Electrophoresis. 2015 Aug;36(15):1754-8. doi: 10.1002/elps.201400510. Epub 2015 Jul 14.

PMID:
25931050
33.

Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial.

Stagl JM, Bouchard LC, Lechner SC, Blomberg BB, Gudenkauf LM, Jutagir DR, Glück S, Derhagopian RP, Carver CS, Antoni MH.

Cancer. 2015 Jun 1;121(11):1873-81. doi: 10.1002/cncr.29076. Epub 2015 Mar 23.

34.

Comparative effectiveness analysis of monotherapy with cytotoxic agents in triple-negative metastatic breast cancer in a community setting.

Dranitsaris G, Gluck S, Faria C, Cox D, Rugo H.

Clin Ther. 2015 Jan 1;37(1):134-44. doi: 10.1016/j.clinthera.2014.10.023. Epub 2014 Nov 26.

PMID:
25433768
35.

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?

Yepes MM, Romilly AP, Collado-Mesa F, Net JM, Kiszonas R, Arheart KL, Young D, Glück S.

Breast Cancer Res Treat. 2014 Nov;148(1):117-23. doi: 10.1007/s10549-014-3143-z. Epub 2014 Sep 28.

PMID:
25262341
36.
37.

Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer.

Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, Glück S, Silva O, Ahn ER.

Clin Breast Cancer. 2015 Feb;15(1):e1-11. doi: 10.1016/j.clbc.2014.08.001. Epub 2014 Aug 15.

PMID:
25241299
38.

Circulating tumor cells in breast cancer.

Pukazhendhi G, Glück S.

J Carcinog. 2014 Jun 30;13:8. doi: 10.4103/1477-3163.135578. eCollection 2014. Review.

39.

Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy.

Bayraktar S, Royce M, Stork-Sloots L, de Snoo F, Glück S.

Med Oncol. 2014 Oct;31(10):163. doi: 10.1007/s12032-014-0163-9. Epub 2014 Sep 4.

PMID:
25186065
40.

Randomized controlled trial of cognitive behavioral stress management in breast cancer: a brief report of effects on 5-year depressive symptoms.

Stagl JM, Antoni MH, Lechner SC, Bouchard LC, Blomberg BB, Glück S, Derhagopian RP, Carver CS.

Health Psychol. 2015 Feb;34(2):176-80. doi: 10.1037/hea0000125. Epub 2014 Jul 28.

41.

Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer.

Diaby V, Adunlin G, Zeichner SB, Avancha K, Lopes G, Gluck S, Montero AJ.

Breast Cancer Res Treat. 2014 Sep;147(2):433-41. doi: 10.1007/s10549-014-3042-3. Epub 2014 Jul 11. Erratum in: Breast Cancer Res Treat. 2014 Sep;147(2):443.

42.

nab-Paclitaxel for the treatment of aggressive metastatic breast cancer.

Glück S.

Clin Breast Cancer. 2014 Aug;14(4):221-7. doi: 10.1016/j.clbc.2014.02.001. Epub 2014 Feb 20. Review.

PMID:
24806278
43.

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.

McIntyre K, O'Shaughnessy J, Schwartzberg L, Glück S, Berrak E, Song JX, Cox D, Vahdat LT.

Breast Cancer Res Treat. 2014 Jul;146(2):321-8. doi: 10.1007/s10549-014-2923-9. Epub 2014 Apr 4. Erratum in: Breast Cancer Res Treat. 2014 Jul;146(2):329.

44.

Extending the clinical benefit of endocrine therapy for women with hormone receptor-positive metastatic breast cancer: differentiating mechanisms of action.

Glück S.

Clin Breast Cancer. 2014 Apr;14(2):75-84. doi: 10.1016/j.clbc.2013.10.008. Epub 2013 Oct 25. Review.

PMID:
24355138
45.

Sleep quality and fatigue after a stress management intervention for women with early-stage breast cancer in southern Florida.

Vargas S, Antoni MH, Carver CS, Lechner SC, Wohlgemuth W, Llabre M, Blomberg BB, Glück S, DerHagopian RP.

Int J Behav Med. 2014 Dec;21(6):971-81. doi: 10.1007/s12529-013-9374-2.

46.

Molecular profiling for breast cancer: a comprehensive review.

Kittaneh M, Montero AJ, Glück S.

Biomark Cancer. 2013 Oct 29;5:61-70. doi: 10.4137/BIC.S9455. Review.

47.

Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis.

Glück S, Russell C, O'Shaughnessy J, McKenna EF, Hu S, Odom D, Blum JL.

Breast. 2013 Dec;22(6):1087-93. doi: 10.1016/j.breast.2013.08.016. Epub 2013 Oct 2.

PMID:
24095220
48.

Biologic impact and clinical implication of mTOR inhibition in metastatic breast cancer.

Westin GF, Perez CA, Wang E, Glück S.

Int J Biol Markers. 2013 Sep 27;28(3):233-41. doi: 10.5301/JBM.5000040. Review.

PMID:
23999849
49.

Participation in cancer clinical trials: why are patients not participating?

Byrne MM, Tannenbaum SL, Glück S, Hurley J, Antoni M.

Med Decis Making. 2014 Jan;34(1):116-26. doi: 10.1177/0272989X13497264. Epub 2013 Jul 29.

PMID:
23897588
50.

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy.

Glück S, de Snoo F, Peeters J, Stork-Sloots L, Somlo G.

Breast Cancer Res Treat. 2013 Jun;139(3):759-67. doi: 10.1007/s10549-013-2572-4. Epub 2013 Jun 12.

PMID:
23756626

Supplemental Content

Support Center